°­¿ø´ëÇб³º´¿ø

½ºÅµ³×ºñ°ÔÀ̼Ç

°Ë»ö ¹Ù·Î°¡±â ÄÜÅÙÃ÷ ¹Ù·Î°¡±â ±Û·Î¹ú¸Þ´º ¹Ù·Î°¡±â ǪÅÍ ¹Ù·Î°¡±â

½ºÆÌ¸Þ´º

º´¿øÈ¨ ·Î±×ÀΠȸ¿ø°¡ÀÔ »çÀÌÆ®¸Ê

Àüü¸Þ´º

ÄÜÅÙÃ÷

ºñ±Þ¿© Áø·áºñ¿ë¾È³»

ºñ±Þ¿© Ç׸ñ ¾È³»

ÀÇ·á¹ý Á¦45Á¶(ºñ±Þ¿© Ç׸ñ¾È³» µîÀÇ °íÁö)¿¡ °üÇÏ¿© ´ÙÀ½°ú °°ÀÌ °­¿ø´ëÇб³º´¿øÀÇ ºñ±Þ¿© Ç׸ñÀ» °Ô½ÃÇÕ´Ï´Ù.

* óġ ¹× ¼ö¼úÀÇ °æ¿ì ÀÔ¿ø·á, ¸¶Ãë·á, ¾àÁ¦·á, Ä¡·áÀç·á µîÀº º°µµ»êÁ¤ µË´Ï´Ù.


ºÐ·ù Ç׸ñ °¡°ÝÁ¤º¸(´ÜÀ§:¿ø) ƯÀÌ
»çÇ×
¸íĪ ÄÚµå ±¸ºÐ ºñ¿ë ÃÖÀúºñ¿ë ÃÖ°íºñ¿ë Ä¡·áÀç·á´ë
Æ÷ÇÔ¿©ºÎ
¾àÁ¦ºñ
Æ÷ÇÔ¿©ºÎ
±âŸÇ÷Áß¾à¹°ÃøÁ¤Ecstasy(MDMA)(À§Å¹)11,330À§Å¹
±âŸfugl-meyer °Ë»ç(RH)½ÅÀÇ·á12,700
±âŸÀÎÁöÁßÀçÄ¡·á(ÃÊÁø °³ÀÎÇü)½ÅÀÇ·á50,000
±âŸÀÎÁöÁßÀçÄ¡·á(ÀçÁø °³ÀÎÇü)½ÅÀÇ·á40,000
±âŸÀÎÁöÁßÀçÄ¡·á(ÃÊÁø ±×·ìÇü)½ÅÀÇ·á30,000
±âŸÀÎÁöÁßÀçÄ¡·á(ÀçÁø ±×·ìÇü)½ÅÀÇ·á20,000
±âŸ(ºñ±Þ¿©)°íºóµµ Áøµ¿ ȯ±â¿ä¹ý(1ÀÏ´ç)½ÅÀÇ·á131,530
±âŸ³»½Ã°æ ±Í¼ö¼ú(º¸Á¶Àû)½ÅÀÇ·á250,000
±âŸ³»½Ã°æ ±Í¼ö¼ú(´Üµ¶)½ÅÀÇ·á1,200,000
±âŸ¶óÄÚ»ç¹Ìµå [Á¤¹ÐºÐ±¤/Áú·®ºÐ¼®]½ÅÀÇ·á64,900
±âŸADAMTS 13 activity½ÅÀÇ·á220,000
±âŸUS, VABE(1ºÎÀ§)½ÅÀÇ·á600,000
±âŸUS, VABE(1ºÎÀ§)_¸¶Ä¿½ÅÀÇ·á700,000
±âŸUS, VABE (µ¿Ãø, 2ºÎÀ§)½ÅÀÇ·á825,000
±âŸUS, VABE(µ¿Ãø, 2ºÎÀ§)_¸¶Ä¿½ÅÀÇ·á925,000
±âŸHLA B51 PCR70,455À§Å¹
±âŸ³ªÀ̽º(NICE) °Ë»ç605,000À§Å¹
±âŸTrisomy 13,18,21,X,Y (QF-PCR)353,210À§Å¹
±âŸ¹Ì¿°»ö½½¶óÀ̵åÁ¦ÀÛ/1Àå´ç(³ª550)8,400
±âŸ¿°»ö½½¶óÀ̵å Á¦ÀÛ10,600
 Ã³À½   ÀÌÀü   21  22  23  24  25  26  27  28  29  30   ´ÙÀ½   ¸¶Áö¸· 
À§·Î°¡±â

¹è³Ê

¿ì)24289 °­¿øÆ¯º°ÀÚÄ¡µµ Ãáõ½Ã ¹é·É·Î 156 °­¿ø´ëÇб³º´¿ø, ´ëÇ¥ÀüÈ­ 033-258-2000
copyright(c) 2010 KNUH.OR.KR ALL RIGHTS RESERVED.
°³ÀÎÁ¤º¸Ã³¸®¹æÄ§ À̸ÞÀÏÁÖ¼Ò ¼öÁý°ÅºÎ ȯÀڱǸ®ÀåÀü
º» »çÀÌÆ®´Â ÀÎÅÍ³Ý ÀͽºÇ÷η¯(IE11)¿¡ ÃÖÀûÈ­µÇ¾ú½À´Ï´Ù.